All Q2 FY27 results →
IC

Indogulf Cropsciences Ltd

Q2 FY27

Indogulf Cropsciences Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹62
Market cap₹391 Cr
P/E10.2
Updated2 Nov 2026
Read3 min read

Based on Indogulf Cropsciences Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY27 Revenue from Operations: INR 2,558 million, a 3% year-on-year (YoY) increase from INR 2,483 million in Q2 FY26 (Page 29, 22, 26). Q2 FY27 EBITDA: INR 406 Mn, a 27% year-on-year (YoY) increase (Page 22, 29) - Q2 FY27 Operating Revenue: INR 2,558 Mn, a 3% YoY increase (Page 22, 29) - Q2 FY27 PAT: INR 257 Mn, a 24% YoY increase

From Indogulf Cropsciences Ltd's Q2 FY27 earnings-call transcript · updated 2 Nov 2026.

Revenue & Sales Performance

  • Q2 FY27 Revenue from Operations: INR 2,558 million, a 3% year-on-year (YoY) increase from INR 2,483 million in Q2 FY26 (Page 29, 22, 26).
  • H1 FY27 Revenue from Operations: INR 4,243 million, a 3% YoY decrease from INR 4,377 million in H1 FY26 (Page 29, 22).
  • Revenue mix for H1 FY27: B2C 59%, B2B 35%, Exports 6% (Page 24).
  • Business verticals for H1 FY27 revenue: Crop Protection 85%, Biologicals 6%, Plant Nutrients 5%, Others 4% (Page 23).

2 more points from Indogulf Cropsciences Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Indogulf Cropsciences Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Expansion underway for dry flowable plant at Barwasni, Haryana facility (Page 19).
  • Setting up dedicated Climate Stress Management & Plant Growth Regulators (PGR) plant at Barwasni (Page 19).
  • Manufacturing capacity utilization improving from 44% in FY23 to 60% in H1FY27, indicating operational scale-up (Page 19).
  • Overall focus on strengthening manufacturing backbone for long-term scalable growth and improving operational efficiencies and product mix (Page 19).

Fundraising & Capital Structure

See what Indogulf Cropsciences Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Indogulf Cropsciences Ltd said on order book & pipeline — free account, 30 seconds.

Indogulf Cropsciences Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹256 Cr, net profit ₹26 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Indogulf Cropsciences Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Indogulf Cropsciences Ltd Q2 FY27 results?

Q2 FY27 Revenue from Operations: INR 2,558 million, a 3% year-on-year (YoY) increase from INR 2,483 million in Q2 FY26 (Page 29, 22, 26). Q2 FY27 EBITDA: INR 406 Mn, a 27% year-on-year (YoY) increase (Page 22, 29) - Q2 FY27 Operating Revenue: INR 2,558 Mn, a 3% YoY increase (Page 22, 29) - Q2 FY27 PAT: INR 257 Mn, a 24% YoY increase

What is Indogulf Cropsciences Ltd share price analysis?

Indogulf Cropsciences Ltd currently shows a neutral. The stock trades at a P/E of 10.2 with a market cap of ₹391 Cr. Investors should review the full earnings analysis for detailed insights.

Is Indogulf Cropsciences Ltd planning capital expenditure?

Expansion underway for dry flowable plant at Barwasni, Haryana facility (Page 19).

Keep Indogulf Cropsciences Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.